NeuralEdge AI Group
Dashboard
TTM through Mar 2026 · QuickBooks Online · Last sync 2h ago
TTM Revenue
$14.2M
+28.4% YoY
Adj. EBITDA
$3.11M
21.9% margin
Gross Margin
42.8%
−180 bps QoQ
Cash Runway
14.2 mo
$2.4M cash · burn $169K
Revenue · last 24 months
Monthly recurring
Top signals
View all 8Customer concentration
HighTop customer "Helix Bio" = 18.4% of TTM revenue.
Gross margin compression
Med−180 bps QoQ driven by COGS inflation.
DSO trending up
MedDSO 47d → 61d over last two quarters.
Net retention > 120%
PosNRR 124% — best-in-class for vertical SaaS.
Diligence progress
View checklistRecent activity
QBO sync completed · 2h ago
Pulled 1,847 GL entries, 3 new customers
New signal: Customer concentration · 4h ago
Helix Bio crossed 18% threshold
Report generated: Q4 QoE Summary · yesterday
By Rocky Hill · 22 pages
Checklist item completed · 2d ago
"Verify revenue recognition policy" by Rocky
Financials
P&L, Balance Sheet, Cash Flow · normalized from QuickBooks
| Line item | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | TTM |
|---|---|---|---|---|---|---|
| Subscription revenue | 2,612,440 | 2,891,200 | 3,124,800 | 3,402,000 | 3,790,000 | 13,208,000 |
| Services revenue | 198,000 | 212,400 | 241,800 | 258,640 | 289,600 | 1,000,440 |
| Total revenue | 2,810,440 | 3,103,600 | 3,366,600 | 3,660,640 | 4,079,600 | 14,208,440 |
| Cost of revenue | (1,587,400) | (1,742,200) | (1,891,400) | (2,156,800) | (2,348,200) | (8,138,600) |
| Gross profit | 1,223,040 | 1,361,400 | 1,475,200 | 1,503,840 | 1,731,400 | 6,069,840 |
| Gross margin % | 43.5% | 43.9% | 43.8% | 41.1% | 42.4% | 42.8% |
| Sales & Marketing | (412,800) | (458,400) | (484,200) | (521,800) | (589,400) | (2,053,800) |
| Research & Development | (298,200) | (312,600) | (341,800) | (368,400) | (401,200) | (1,424,200) |
| General & Administrative | (186,800) | (195,400) | (208,400) | (224,800) | (241,800) | (870,400) |
| Adj. EBITDA | 325,240 | 395,000 | 440,800 | 388,840 | 499,000 | 3,105,672 |
| EBITDA margin % | 11.6% | 12.7% | 13.1% | 10.6% | 12.2% | 21.9% |
Balance Sheet — same table structure as P&L (mock placeholder).
Cash Flow — same table structure as P&L (mock placeholder).
Analytics
Trends, cohorts, margin and concentration analysis
Revenue growth
YoY % per month
Gross margin
Quarterly trend
Customer concentration
Top 10 customers · TTM
| Customer | Revenue | % of total |
|---|---|---|
| Helix Bio | 2,614,353 | 18.4% |
| Northwind Logistics | 1,278,761 | 9.0% |
| Cascade Health | 994,591 | 7.0% |
| Atlas Manufacturing | 781,464 | 5.5% |
| Bluepeak Capital | 639,380 | 4.5% |
| — 5 more — | 2,283,054 | 16.1% |
| Top 10 | 8,591,603 | 60.5% |
Net revenue retention
Quarterly cohort
Signals
8 active signals · 3 high · 4 med · 1 positive
Customer concentration risk — Helix Bio at 18.4% of TTM revenue
Helix Bio's contribution increased from 12.1% in Q1 2025 to 18.4% in TTM Q1 2026, exceeding the 15% threshold typically flagged by buyers. Contract renews March 2027.
Unusual journal entry pattern — Q4 2025 month-end
12 manual JEs posted on Dec 31, 2025 totaling $284K of revenue. Z-score 3.2 against rolling 24-month baseline. Possible cut-off issue; review before close.
Gross margin compression — −180 bps QoQ
Gross margin compressed from 43.8% (Q3 2025) to 42.0% (Q4 2025) and 42.4% (Q1 2026), driven by 14% YoY increase in third-party AI inference costs.
Days sales outstanding trending up
DSO increased from 47 days (Q3 2025) to 61 days (Q1 2026). Three customers — Helix Bio, Atlas Mfg, Cascade Health — account for 78% of the $312K growth in AR.
Vendor concentration — OpenAI 31% of COGS
Single-vendor dependency on OpenAI for inference. Pricing/availability changes would directly impact margins. Recommend documenting redundancy plan.
Net revenue retention 124% — top quartile
NRR has held above 115% for 6 consecutive quarters, reaching 124% in Q1 2026. Best-in-class for vertical SaaS at this revenue scale.
Valuation
EBITDA-multiple valuation, 5-year projections, IRR sensitivity
Inputs
Software · vertical SaaS · $10-25M revenue: median 7.8x · 75th pct 9.4x
Indicative valuation
Low (7.5x)
$23.3M
Base (8.5x)
$26.4M
High (10x)
$31.1M
IRR sensitivity
Entry multiple (rows) × Exit multiple (columns) · 5-year hold · 22% CAGR
| Entry / Exit | 7.0x | 8.0x | 9.0x | 10.0x | 11.0x |
|---|
5-year projection
Revenue and EBITDA
Checklists
Quality of Earnings · 14 of 18 complete · Due Apr 30
Rocky Hill · 2d ago · 3 attachments
Rocky Hill · 4d ago · $312K identified
Assigned to Rocky · due Apr 28
Unassigned · due Apr 30
Unassigned · due Apr 30
Unassigned · due May 5
Reports
Investor-grade PDFs and presentation decks
QoE Report
Q4 2025 Quality of Earnings
22 pages · 4.2 MB · Mar 18
IOI Deck
Indication of Interest
9 slides · 1.8 MB · Mar 14
Diligence Summary
Pre-LOI Diligence
14 pages · 3.1 MB · Mar 8
| Name | Type | Created by | Created | Size |
|---|---|---|---|---|
| Q4 2025 Quality of Earnings | QoE | Rocky Hill | Mar 18, 2026 | 4.2 MB |
| Indication of Interest | IOI | Rocky Hill | Mar 14, 2026 | 1.8 MB |
| Pre-LOI Diligence Summary | Diligence | Rocky Hill | Mar 8, 2026 | 3.1 MB |
| Initial Financial Review | Memo | Rocky Hill | Feb 24, 2026 | 920 KB |
Integrations
Connect accounting systems and data sources
Connected
QuickBooks Online
ActiveLast sync 2h ago · 1,847 GL entries · 23 customers · 47 vendors
Available
Xero
OAuth connection — pulls chart of accounts, GL, contacts.
Sage Intacct
API credentials — pulls normalized accounting data.
NetSuite
SuiteCloud OAuth — pulls accounting and operational data.
CSV upload
Upload trial balance, GL export, or normalized P&L/BS.
Admin
Workspace settings, members, and billing
Workspace
- Name
- NeuralEdge AI Group
- Slug
- neuraledge-ai-group
- Industry
- Software & AI
- Currency
- USD
- Fiscal year end
- December
- Created
- Apr 22, 2026
Members
1 total
Rocky Hill
rocky.hill@almcoe.online